StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
EUDA$16.73-7.38%
Fair $16.73+0.0%

EUDA

EUDA Health Holdings Limited

Real Estate / Real Estate ServicesNasdaqCM

$16.73

-1.33 (-7.38%)

Fairly Valued+0.0%Fair Value $16.73Fund rank 28/100 · Data gapFallback financials|
SA 32/D
F-Score: 5/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 100.0/100

Data gap 28/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

20/100

SEC 0%

Latest source: unknownPeriods: 5Warnings: 0unknown: 5
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific NAV/AFFO model required: REIT/real-estate targets are disabled until FFO/AFFO/NAV/cap-rate data exists. REIT NAV/AFFO valuation requires positive AFFO/share history or TTM AFFO/share; generic FCF remains disabled.
Thesis & Journal · EUDALocal privado en este navegador · EUDA Health Holdings Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$50M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

65.2%

↑

Gross Margin

43.9%

↑

Debt/Equity

-0.56

↓
52-Week Range$17
$5$86

TradingView lightweight chart

EUDA price, volumen y niveles de valoración

Último $16.73Periodo -91.3%
Fair value: $16.73

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2025 · 4 años de histórico normalizado

Revenue CAGR

-10.3%

FCF CAGR

—

FCF margin

-37.1%

FCF / Net income

0.91x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $6.8M · net income $-2.8M · FCF $-2.5M

2021-FY → 2025-FY

Gross margin

43.9%+3.6% pts

Operating margin

-35.8%-24.1% pts

Net margin

-40.7%-48.9% pts

FCF margin

-37.1%-41.3% pts
MetricTTM
2025
2024
2023
2022
2021
Income Statement
Revenue$6.8M$6.8M$4.0M$3.7M$3.8M$10.5M
Net Income$-2.8M$-2.8M$-15.4M$-10.0M$-24.9M$864829.00
EBITDA$-2.1M$-2.1M$-17.4M$-8.3M$-24.8M—
EPS——-9.46-8.77-41.401.80
Gross Margin43.9%43.9%19.0%22.7%23.1%40.3%
Operating Margin-35.8%-35.8%-64.3%-106.9%-156.2%-11.6%
Net Margin-40.7%-40.7%-382.9%-270.9%-661.1%8.2%
Balance Sheet
Debt/Equity-0.56-0.56-0.50-0.45-1.03—
Current Ratio0.180.18————
Cash Flow
Free Cash Flow$-2.5M$-2.5M$-2.2M$-2.9M$-1.5M$441963.00
Returns
ROE65.2%65.2%601.5%133.9%706.8%165.9%
Growth & Yield
Revenue Growth70.0%70.0%8.2%-1.5%——
EPS Growth——-7.9%78.8%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -77.1%

Total return

-77.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-9.46 → n/d

Residual

-77.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-77.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.